Projection of Diabetic Retinopathy and Other Major Eye Diseases Among People With Diabetes Mellitus

Abstract

Objectives:To estimate the number of people with diabetic retinopathy (

The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus

“…Due to changes in lifestyle and increase in ageing populations, the prevalence of ophthalmic complications is rising worldwide [43]. This is consistent with our study that people >60 years had higher incidence and cost of ophthalmic complications.…”

The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus

“…Due to changes in lifestyle and increase in ageing populations, the prevalence of ophthalmic complications is rising worldwide [43]. This is consistent with our study that people >60 years had higher incidence and cost of ophthalmic complications.…”

Switching To Less Expensive Blindness Drug Could Save Medicare Part B $18 Billion Over A Ten-Year Period

“…21,25,37,38 Overall spending in 2010 on bevacizumab and ranibizumab as predicted by our model is similar to data reported by the HHS Office of Inspector General, helping to validate the model 4,5 (Appendix Exhibit A7). 22 …”

eNOS [Glu298Asp] polymorphism, erectile function and ocular pressure in type 2 diabetes

“…of systemic b-blockers or diuretics on ocular pressure [49]. Cataract prevalence in this study was similar to US Caucasians 65-74 years [36]. The natural history of cataract underlies an avascular process, with NO involved to a lesser extent.…”

The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus

“…Due to changes in lifestyle and increase in ageing populations, the prevalence of ophthalmic complications is rising worldwide [43]. This is consistent with our study that people >60 years had higher incidence and cost of ophthalmic complications.…”

Switching To Less Expensive Blindness Drug Could Save Medicare Part B $18 Billion Over A Ten-Year Period

“…21,25,37,38 Overall spending in 2010 on bevacizumab and ranibizumab as predicted by our model is similar to data reported by the HHS Office of Inspector General, helping to validate the model 4,5 (Appendix Exhibit A7). 22 …”

eNOS [Glu298Asp] polymorphism, erectile function and ocular pressure in type 2 diabetes

“…of systemic b-blockers or diuretics on ocular pressure [49]. Cataract prevalence in this study was similar to US Caucasians 65-74 years [36]. The natural history of cataract underlies an avascular process, with NO involved to a lesser extent.…”

The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus

“…Due to changes in lifestyle and increase in ageing populations, the prevalence of ophthalmic complications is rising worldwide [43]. This is consistent with our study that people >60 years had higher incidence and cost of ophthalmic complications.…”

Switching To Less Expensive Blindness Drug Could Save Medicare Part B $18 Billion Over A Ten-Year Period

“…21,25,37,38 Overall spending in 2010 on bevacizumab and ranibizumab as predicted by our model is similar to data reported by the HHS Office of Inspector General, helping to validate the model 4,5 (Appendix Exhibit A7). 22 …”

eNOS [Glu298Asp] polymorphism, erectile function and ocular pressure in type 2 diabetes

“…of systemic b-blockers or diuretics on ocular pressure [49]. Cataract prevalence in this study was similar to US Caucasians 65-74 years [36]. The natural history of cataract underlies an avascular process, with NO involved to a lesser extent.…”